Your browser doesn't support javascript.
loading
FBXW7 in Cancer: What Has Been Unraveled Thus Far?
Sailo, Bethsebie Lalduhsaki; Banik, Kishore; Girisa, Sosmitha; Bordoloi, Devivasha; Fan, Lu; Halim, Clarissa Esmeralda; Wang, Hong; Kumar, Alan Prem; Zheng, Dali; Mao, Xinliang; Sethi, Gautam; Kunnumakkara, Ajaikumar Bahulayan.
Afiliação
  • Sailo BL; Cancer Biology Laboratory and DBT-AIST International Laboratory for Advanced Biomedicine (DAILAB), Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati, Assam-781039, India. bethsailo@gmail.com.
  • Banik K; Cancer Biology Laboratory and DBT-AIST International Laboratory for Advanced Biomedicine (DAILAB), Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati, Assam-781039, India. kishore.banik@iitg.ernet.in.
  • Girisa S; Cancer Biology Laboratory and DBT-AIST International Laboratory for Advanced Biomedicine (DAILAB), Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati, Assam-781039, India. sosmi176106101@iitg.ac.
  • Bordoloi D; Cancer Biology Laboratory and DBT-AIST International Laboratory for Advanced Biomedicine (DAILAB), Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati, Assam-781039, India. devivasha@iitg.ac.in.
  • Fan L; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117 600, Singapore. phcfanl@nus.edu.sg.
  • Halim CE; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117 600, Singapore. phsceh@nus.edu.sg.
  • Wang H; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117 600, Singapore. snrwh@nus.edu.sg.
  • Kumar AP; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117 600, Singapore. csiapk@nus.edu.sg.
  • Zheng D; Cancer Science Institute of Singapore, National University of Singapore, Singapore 117 600, Singapore. csiapk@nus.edu.sg.
  • Mao X; Medical Science Cluster, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117 600, Singapore. csiapk@nus.edu.sg.
  • Sethi G; Curtin Medical School, Faculty of Health Sciences, Curtin University, 6845, Perth WA, Australia. csiapk@nus.edu.sg.
  • Kunnumakkara AB; The School of Stomatology, Fujian Medical University, 1 Xue Yuan Road, University Town, FuZhou Fujian 350108, China. dalizheng@hotmail.com.
Cancers (Basel) ; 11(2)2019 Feb 19.
Article em En | MEDLINE | ID: mdl-30791487
: The FBXW7 (F-box with 7 tandem WD40) protein encoded by the gene FBXW7 is one of the crucial components of ubiquitin ligase called Skp1-Cullin1-F-box (SCF) complex that aids in the degradation of many oncoproteins via the ubiquitin-proteasome system (UPS) thus regulating cellular growth. FBXW7 is considered as a potent tumor suppressor as most of its target substrates can function as potential growth promoters, including c-Myc, Notch, cyclin E, c-JUN, and KLF5. Its regulators include p53, C/EBP-δ, Numb, microRNAs, Pin 1, Hes-5, BMI1, Ebp2. Mounting evidence has indicated the involvement of aberrant expression of FBXW7 for tumorigenesis. Moreover, numerous studies have also shown its role in cancer cell chemosensitization, thereby demonstrating the importance of FBXW7 in the development of curative cancer therapy. This comprehensive review emphasizes on the targets, functions, regulators and expression of FBXW7 in different cancers and its involvement in sensitizing cancer cells to chemotherapeutic drugs.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article